Tore Kvien
Universitetet i Oslo
H-index: 136
Europe-Norway
Top articles of Tore Kvien
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Corrigendum to “Study protocol for the follow-up examination of the Nor-Hand study: A hospital-based observational cohort study exploring pain and biomarkers in people with … | Osteoarthritis and Cartilage Open | Marthe Gløersen Pernille Steen Pettersen Øystein Maugesten Elisabeth Mulrooney Alexander Mathiessen | 2024/3/1 |
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis | Journal of Autoimmunity | Xuan Zhang Jun Xia Ying Jiang David S Pisetsky Josef S Smolen | 2024/1/1 |
Definition of rheumatoid arthritis flare based on SDAI and CDAI | Annals of the Rheumatic Diseases | Victoria Konzett Andreas Kerschbaumer Josef S Smolen Eirik Klami Kristianslund Sella A Provan | 2024/2/1 |
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA … | Joint Bone Spine | Kim Lauper Denis Mongin Sytske Anne Bergstra Denis Choquette Catalin Codreanu | 2024/3/1 |
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year … | The Lancet Rheumatology | Kaja E Kjørholt Nina Paulshus Sundlisæter Anna-Birgitte Aga Joseph Sexton Inge C Olsen | 2024/4/4 |
T Cell Responses to Repeated SARS-CoV-2 Vaccination and Breakthrough Infections in Patients on TNF Inhibitor Treatment: A Prospective Cohort Study | Asia-Sophia Wolf Kristin Hammersbøen Bjørlykke Hilde S Ørbo Sabin Bhandari Guri Solum | 2024 | |
Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region | Khalid A Alnaqbi Nasra Al Adhoubi Sara Aldallal Samar Al Emadi Adeeba Al-Herz | 2024/2/25 | |
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis–does it depend on the reason for withdrawal from the previous treatment? | Joint bone spine | Lykke Midtbøll Ørnbjerg Cecilie Heegaard Brahe Louise Linde Lennart Jacobsson Michael J Nissen | 2024/4/4 |
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity | RMD open | Karen Holten Nina Paulshus Sundlisæter Joseph Sexton Lena Bugge Nordberg Till Uhlig | 2024/1/1 |
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials | The Lancet Rheumatology | Marthe Kirkesæther Brun Johanna E Gehin Kristin Hammersbøen Bjørlykke David John Warren Rolf A Klaasen | 2024/2/22 |
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD … | RMD open | Hilde S Ørbo Kristin H Bjørlykke Joseph Sexton Ingrid Jyssum Anne T Tveter | 2024/4/1 |
Generic Tofacitinib—A More Affordable JAK Inhibitor | Mayo Clinic Proceedings | Guro L Goll Tore K Kvien | 2024/1/1 |
Hand osteoarthritis phenotypes based on a biopsychosocial approach, and their associations with cross-sectional and longitudinal pain | Osteoarthritis and Cartilage | Elisabeth Mulrooney Tuhina Neogi Hanne Dagfinrud Hilde Berner Hammer Pernille Steen Pettersen | 2024/4/30 |
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’study) | Annals of the rheumatic diseases | Romain Aymon Denis Mongin Sytske Anne Bergstra Denis Choquette Catalin Codreanu | 2024/4/1 |
A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study | Scandinavian Journal of Rheumatology | SA Provan F Ahlfors G Bakland Y Hu EK Kristianslund | 2024/2/6 |
Biosimilar tocilizumab—better access and lower cost? | The Lancet Rheumatology | Guro L Goll Tore K Kvien | 2024/1/1 |
ASDAS-CRP and ASDAS-ESR cut-offs for disease activity states in axial spondyloarthritis–Are they interchangeable? | The Journal of Rheumatology | Stylianos Georgiadis Lykke Midtbøll Ørnbjerg Brigitte Michelsen Tore K Kvien Daniela Di Giuseppe | 2024/4/15 |
Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international … | Journal of Clinical Epidemiology | Celina K Gehringer Glen P Martin Kimme L Hyrich Suzanne MM Verstappen Joseph Sexton | 2024/2/1 |
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study | The Lancet Rheumatology | Kristin H Bjørlykke Hilde S Ørbo Anne T Tveter Ingrid Jyssum Joseph Sexton | 2023/1/1 |
Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents | Scandinavian Journal of Rheumatology | AM Kerola S Rollefstad Amirhossein Kazemi Grunde Wibetoe Joseph Sexton | 2023/1/2 |
